MARKET

XBI

XBI

SPDR® S&P Biotech ETF
NYSEARCA
79.45
+3.06
+4.01%
After Hours: 79.65 +0.2 +0.25% 19:55 05/12 EDT
OPEN
78.05
PREV CLOSE
76.39
HIGH
80.07
LOW
77.87
VOLUME
19.55M
TURNOVER
--
52 WEEK HIGH
105.46
52 WEEK LOW
66.66
TOTAL ASSET
4.80B
YTD YIELD
-9.66%
1D
5D
1M
3M
1Y
5Y
1D
Drugmakers Spared Worst-Case Drug Pricing Scenario for Now
The Wall Street Journal · 13h ago
Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet
Seeking Alpha · 14h ago
XBI: Some Tariff Relief Right Now, But Macro Risks Remain In Biotech
Seeking Alpha · 15h ago
Intellia Therapeutics Shares Have Struggled, But It's Now Go-Time (Rating Upgrade)
Seeking Alpha · 17h ago
Surprise Breakthrough: US-China Talks Spark Market Rally
NASDAQ · 17h ago
Weekly Report: what happened at XBI last week (0505-0509)?
Weekly Report · 20h ago
Trump vows to cut drug prices in the U.S. by up to 80%
Seeking Alpha · 1d ago
Healthcare stocks that could be poised for a rebound
Seeking Alpha · 3d ago
More
Profile
Fund Name
SPDR® S&P Biotech ETF
Inception Date
2006-01-31
Benchmark
S&P Biotechnology Select Industry TR USD
Advisor Company
SPDR State Street Global Advisors
Custodian
State Street Bank & Trust Co
Manager
Michael Feehily, Raymond Donofrio, Karl Schneider
Recently
Symbol
Price
%Change